Literature DB >> 15764853

Complement dependent trapping of infectious HIV in human lymphoid tissues.

Zoltán Bánki1, Laco Kacani, Peter Rusert, Monika Pruenster, Doris Wilflingseder, Barbara Falkensammer, Hans-Jürgen Stellbrink, Jan van Lunzen, Alexandra Trkola, Manfred P Dierich, Heribert Stoiber.   

Abstract

OBJECTIVES: HIV-1 bound extracellularly to follicular dendritic cells (FDC) in germinal centers (GC) of lymphoid tissues (LT) represents the largest viral reservoir in HIV-infected individuals; however there is no direct evidence as to whether HIV trapped in human GC remains infectious. In the GC, complement receptors and Fc gamma receptors have been suggested to participate in trapping of HIV; therefore, the relative contribution of complement- and Fc gamma receptors in binding HIV on LT was investigated and the infectivity of this virus was tested.
DESIGN: As it is difficult to isolate FDC without contaminations of productively infected cells, HIV was detached from LT of HIV positive individuals using antibodies blocking complement- and Fc gamma receptors. Isolated virus was tested in an infectivity assay.
METHODS: HIV detached from LT was quantified by HIV p24 ELISA, PCR and in an in vitro infectivity assay. Presence and accessibility of viral envelope proteins, complement factors and immunoglobulins on the surface of detached viral particles were evaluated through viral capture by respective antibodies.
RESULTS: Although both C3d-fragments and IgG molecules were identified on the surface of HIV detached from LT, trapping of HIV was mediated solely by CR2-C3d interactions, whereas contribution of Fc gamma receptors was not detectable. Infectivity assays with HIV stripped from LT of HIV positive individuals revealed that in four out of ten patients HIV particles were infectious.
CONCLUSIONS: These findings indicate that in the GC infectious virus is trapped on CR2-expressing FDC (or B cells). Reduction of this pool of HIV could be a therapeutic goal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764853     DOI: 10.1097/01.aids.0000162336.20439.8d

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  16 in total

1.  FDC:TFH Interactions within Cervical Lymph Nodes of SIV-Infected Rhesus Macaques.

Authors:  Rajnish S Dave; Ravi K Sharma; Roshell R Muir; Elias Haddad; Sanjeev Gumber; Francois Villinger; Artinder P Nehra; Zafar K Khan; Brian Wigdahl; Aftab A Ansari; Siddappa N Byrareddy; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-12-29       Impact factor: 4.147

2.  Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Authors:  Zoltán Bánki; Wilfried Posch; Asim Ejaz; Verena Oberhauser; Suzanne Willey; Christoph Gassner; Heribert Stoiber; Ulf Dittmer; Manfred P Dierich; Kim J Hasenkrug; Doris Wilflingseder
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

Review 3.  Viruses exploit the tissue physiology of the host to spread in vivo.

Authors:  Xaver Sewald; Nasim Motamedi; Walther Mothes
Journal:  Curr Opin Cell Biol       Date:  2016-05-03       Impact factor: 8.382

4.  A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.

Authors:  Yuanyong Xu; Chuanfu Zhang; Leili Jia; Cuirong Wen; Huihui Liu; Yong Wang; Yansong Sun; Liuyu Huang; Yusen Zhou; Hongbin Song
Journal:  Virol J       Date:  2009-08-12       Impact factor: 4.099

5.  Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission.

Authors:  Niki M Moutsopoulos; Salvador Nares; Nikolaos Nikitakis; Zoila Rangel; Jie Wen; Peter Munson; John Sauk; Sharon M Wahl
Journal:  Am J Pathol       Date:  2007-07-09       Impact factor: 4.307

6.  A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.

Authors:  Maria E Moreno-Fernandez; Julio Aliberti; Sander Groeneweg; Jörg Köhl; Claire A Chougnet
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-15       Impact factor: 2.205

7.  Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain.

Authors:  Thaidra Gaufin; Rajeev Gautam; Melissa Kasheta; Ruy Ribeiro; Erin Ribka; Mary Barnes; Melissa Pattison; Coty Tatum; Jeanne MacFarland; David Montefiori; Amitinder Kaur; Ivona Pandrea; Cristian Apetrei
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

8.  MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1.

Authors:  Claudia R Ruprecht; Anders Krarup; Lucy Reynell; Axel M Mann; Oliver F Brandenberg; Livia Berlinger; Irene A Abela; Roland R Regoes; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  J Exp Med       Date:  2011-02-28       Impact factor: 14.307

Review 9.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

10.  Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.

Authors:  Wilfried Posch; Sylvain Cardinaud; Chiraz Hamimi; Adam Fletcher; Annelies Mühlbacher; Klaus Loacker; Paul Eichberger; Manfred P Dierich; Gianfranco Pancino; Cornelia Lass-Flörl; Arnaud Moris; Asier Saez-Cirion; Doris Wilflingseder
Journal:  J Allergy Clin Immunol       Date:  2012-10-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.